Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. KNSA
KNSA logo

KNSA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KNSA News

Kiniksa Pharmaceuticals International (KNSA.US) Officer Plans to Sell $3.14 Million in Common Stock via Form 144

May 01 2026moomoo

Enphase Energy Drops as Solar Demand Weakens

Apr 29 2026Fool

Kiniksa Pharmaceuticals Reports Strong Q1 Earnings, Shares Surge

Apr 29 2026Fool

Kiniksa Pharmaceuticals Reports Strong Sales Growth

Apr 29 2026NASDAQ.COM

Kiniksa Pharmaceuticals Q1 2026 Earnings Call Highlights

Apr 28 2026seekingalpha

Kiniksa Pharmaceuticals Exceeds Q1 Expectations and Raises Outlook

Apr 28 2026seekingalpha

Kiniksa Pharmaceuticals Q1 Earnings Exceed Expectations

Apr 28 2026seekingalpha

Kiniksa Reports Q1 2026: Significant Growth in ARCALYST Revenue

Apr 28 2026Newsfilter

Kiniksa Pharmaceuticals CFO Sells Shares Amid Strong Performance

Apr 17 2026NASDAQ.COM

Kiniksa Executive Sells Shares, Retains Significant Stake

Apr 17 2026Fool

Futures Drop as March Jobs Report Surprises

Apr 03 2026Yahoo Finance

Stock Market Rises Strongly Despite Soaring Oil Prices

Apr 03 2026Yahoo Finance

Stock Market Rises Strongly Despite Soaring Oil Prices

Apr 03 2026Yahoo Finance

Kiniksa to Speak at TD Cowen Health Conference

Feb 25 2026Yahoo Finance

Kiniksa Pharmaceuticals Q4 2025 Earnings Highlights

Feb 24 2026seekingalpha

Kiniksa Pharmaceuticals Q4 2025 Earnings Report

Feb 24 2026seekingalpha